수종 한약 복합물의 역형성갑상선암세포 SNU-80에 대한 항암효과
Antineoplastic Effect of Several Herbal Medicine Mixtures on SNU-80 Anaplastic Thyroid Carcinoma Cell Line
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: The purpose of this study was to investigate the antineoplastic effect of several herbal medicine mixtures (compositions of Astragalus membranaceu, Angelica gigas, Trichosanthes kirilowii, Panax ginseng, Rhus verniciflua Stokes) on the SNU-80 anaplastic thyroid carcinoma cell line. Methods: MTT assay was used to examine whether our herbal medicine mixtures decreased cell growth rate of SNU-80. Wound healing assay and Transwell invasion assay was performed to investigate whether our herbal medicine mixtures affect the migration and invasion of anaplastic cancer cells, SNU-80. ELISA assay was performed to know if our herbal medicine mixtures suppressed the expression of pro-invasive molecules, such as vascular endothelial growth factor (VEGF) and matrix metalloproteinase-2 (MMP-2) secreted from SNU-80. Results: MTT assay demonstrated that A. membranaceus:A. gigas:T. kirilowii=1:1:1 or 3:1:1, A. membranaceus:A. gigas :T. kirilowii:P. ginseng=1:1:1:1 or 3:1:1:1, A. membranaceus:A. gigas:T. kirilowii:P. ginseng:R. verniciflua Stokes=1:1:1:1:1 or 3:1:1:1:1 strongly suppressed the growth of SNU-80. Wound healing assay demonstrated that A. membranaceus:A. gigas= 3:1, A. membranaceus:A. gigas:T. kirilowii=1:1:1 or 3:1:1, A. membranaceus:A. gigas:T. kirilowii:P. ginseng=1:1:1:1 or 3:1:1:1, A. membranaceus:A. gigas:T. kirilowii:P. ginseng:R. verniciflua Stokes=1:1:1:1:1 or 3:1:1:1:1 inhibited the migration of SNU-80. Transwell invasion assay demonstrated that A. membranaceus:A. gigas=1:1, A. membranaceus:A. gigas:T. kirilowii =1:1:1 or 3:1:1, A. membranaceus:A. gigas:T. kirilowii:P. ginseng=1:1:1:1, A. membranaceus:A. gigas:T. kirilowii:P. ginseng :R. verniciflua Stokes=1:1:1:1:1 or 3:1:1:1:1 inhibited the invasion of SNU-80. ELISA assay demonstrated that A. membranaceus :A. gigas:T. kirilowii=1:1:1 or 3:1:1, A. membranaceus:A. gigas:T. kirilowii:P. ginseng:R. verniciflua Stokes=1:1:1:1:1 suppressed the expression of VEGF. Also, A. membranaceus:A. gigas=1:1, A. membranaceus:A. gigas:T. kirilowii=1:1:1 or 3:1:1, A. membranaceus :A. gigas:T. kirilowii:P. ginseng=1:1:1:1 or 3:1:1:1, A. membranaceus:A. gigas:T. kirilowii:P. ginseng:R. verniciflua Stokes =1:1:1:1:1 or 3:1:1:1:1 suppressed the expression of MMP-2. Conclusions: The results obtained in this study suggest that several herbal medicine mixtures suppresse the growth and inhibit the migration and invasion of SNU-80, which is anaplastic thyroid cancer cells. Especially, A. membranaceus:A. gigas: T. kirilowii=1:1:1 mixture had a stronger anti-cancer effect.
Abstract
Objectives: The purpose of this study was to investigate the antineoplastic effect of several herbal medicine mixtures (compositions of Astragalus membranaceu, Angelica gigas, Trichosanthes kirilowii, Panax ginseng, Rhus verniciflua Stokes) on the SNU-80 anaplastic thyroid carcinoma cell line. Methods: MTT assay was used to examine whether our herbal medicine mixtures decreased cell growth rate of SNU-80. Wound healing assay and Transwell invasion assay was performed to investigate whether our herbal medicine mixtures affect the migration and invasion of anaplastic cancer cells, SNU-80. ELISA assay was performed to know if our herbal medicine mixtures suppressed the expression of pro-invasive molecules, such as vascular endothelial growth factor (VEGF) and matrix metalloproteinase-2 (MMP-2) secreted from SNU-80. Results: MTT assay demonstrated that A. membranaceus:A. gigas:T. kirilowii=1:1:1 or 3:1:1, A. membranaceus:A. gigas :T. kirilowii:P. ginseng=1:1:1:1 or 3:1:1:1, A. membranaceus:A. gigas:T. kirilowii:P. ginseng:R. verniciflua Stokes=1:1:1:1:1 or 3:1:1:1:1 strongly suppressed the growth of SNU-80. Wound healing assay demonstrated that A. membranaceus:A. gigas= 3:1, A. membranaceus:A. gigas:T. kirilowii=1:1:1 or 3:1:1, A. membranaceus:A. gigas:T. kirilowii:P. ginseng=1:1:1:1 or 3:1:1:1, A. membranaceus:A. gigas:T. kirilowii:P. ginseng:R. verniciflua Stokes=1:1:1:1:1 or 3:1:1:1:1 inhibited the migration of SNU-80. Transwell invasion assay demonstrated that A. membranaceus:A. gigas=1:1, A. membranaceus:A. gigas:T. kirilowii =1:1:1 or 3:1:1, A. membranaceus:A. gigas:T. kirilowii:P. ginseng=1:1:1:1, A. membranaceus:A. gigas:T. kirilowii:P. ginseng :R. verniciflua Stokes=1:1:1:1:1 or 3:1:1:1:1 inhibited the invasion of SNU-80. ELISA assay demonstrated that A. membranaceus :A. gigas:T. kirilowii=1:1:1 or 3:1:1, A. membranaceus:A. gigas:T. kirilowii:P. ginseng:R. verniciflua Stokes=1:1:1:1:1 suppressed the expression of VEGF. Also, A. membranaceus:A. gigas=1:1, A. membranaceus:A. gigas:T. kirilowii=1:1:1 or 3:1:1, A. membranaceus :A. gigas:T. kirilowii:P. ginseng=1:1:1:1 or 3:1:1:1, A. membranaceus:A. gigas:T. kirilowii:P. ginseng:R. verniciflua Stokes =1:1:1:1:1 or 3:1:1:1:1 suppressed the expression of MMP-2. Conclusions: The results obtained in this study suggest that several herbal medicine mixtures suppresse the growth and inhibit the migration and invasion of SNU-80, which is anaplastic thyroid cancer cells. Especially, A. membranaceus:A. gigas: T. kirilowii=1:1:1 mixture had a stronger anti-cancer effect.
참고문헌 (33)
- 류기원, "암에 대한 한의학적 인식 및 실험적 연구에 관한 고찰", 대한한방종양학회지, 1(1), pp.29~54 (1995)
- 崔昇勳, "東醫腫瘍學", pp.13~42 (1995), 杏林書院
- 전통의학연구소, "한의학사전", pp.233~ (2001), 成輔社
- 정재중, "四物湯加味方의 항암효과에 대한 실험적 연구", 대한한방부인과학회지, 23(3), pp.38~55 (2010), 대한한방부인과학회
- 이순남, "말기 암환자의 임종 전 48시간 동안의 임상증상", 한국호스피스완화의료학회지, 10(4), pp.190~194 (2007), 한국호스피스완화의료학회
- Walsh D, "Symptoms and prognosis in advanced cancer", Support care cancer, 10, pp.385~388 (2002)
- 박선동, "當歸補血湯의 배합비율에 따른 대장암 세포주 HCT116의 세포사멸 효과", 대한본초학회지, 21(2), pp.37~46 (2006), 대한본초학회
- 장성일, "인삼의 항암작용에 대한 한의학 관련 논문 분석", 한의학연구소 논문집, 19(2), pp.145~152 (2011), 한의학연구소
- Park SC, "Introduction of apoptosis in human lung carcinoma cells by water extract of Panax notoginseng is associated with the activation of caspase-3 through downregulation of Akt", Internation journal of oncology, 35(1), pp.121~127 (2009)
- 박영철, "한약의 다양한 항암기전", 대한본초학회지, 27(3), pp.39~55 (2012), 대한본초학회
- 이현희, "자궁경부암세포에 대한 天花粉의 성장억제 및 세포사멸효과", 대한한방부인과학회지, 18(3), pp.77~91 (2005), 대한한방부인과학회
- 최태연, "천화분 약침액의 A549 폐암 세포주에서 apoptosis 유발효과", Korean Journal of Acupuncture, 27(4), pp.15~23 (2010), 경락경혈학회
- 최원철, "법제 옻나무 추출물의 혈관형성저해 및 항암효과에 관한 연구", 동의생리병리학회지, 20(4), pp.825~829 (2006), 대한동의병리학회
- 여현수, "황기, 당귀, 칠피, 천화분의 역형성갑상선암세포 SNU-80에 대한 항암효과", 대한예방한의학회지, 18(1), pp.83~92 (2014), 대한예방한의학회
- 대한내과학회, "해리슨내과학", pp.2699~2703 (2010), 도서출판 MIP
- 대한병리학회, "병리학", pp.904~916 (2007), 고문사
- 최현정, "심바스타틴이 미분화 갑상선암 세포주의 성장 및 침습에 미치는 영향", Endocrinology and Metabolism, 23(4), pp.238~244 (2008), 대한내분비학회
- 許浚, "東醫寶鑑", pp.2253~ (2001), 여강출판사
- 傳統文化硏究所, "東洋醫學大辭典", pp.467~1080 (2000), 成輔社
- 김성동, "白花蛇舌草로부터 분리한 ursolic acid의자연살해효과와 항전이작용", 대전대학교한의학연구소논문집, 5(2), pp.523~533 (1997)
- 송호준, "白花蛇舌草 전탕액 투여가 마우스의 항종양 면역반응에 미치는 영향", 본초분과학회지, 9(1), pp.3~97 (1994)
- 邢雪梅, "抗癌中藥의 生物治療效能硏究近況", pp.85~90 (1994), 中醫雜誌
- 이영찬, "파두를 가미한 사군자탕 및 사물탕의 항암효과에 대한 연구", 동의병리생리학회지, 9(1), pp.79~100 (1994)
- 전국한의과대학 본초학공동교재 편집위원회, "本草學", pp.205~477 (2012), 永林社
- 주영증, "약용자원식물학", pp.207~239 (2005), 永林社
- 中藥大辭典 編纂委員會, "中藥大辭典", pp.4374~ (1997), 정담
- Sharma C, "(-)-epigallocatechin-3-gallate induces apoptosis and inhibits invasion and migration of human cervical cancer cells", Asian Pac J Cancer Prev, 13(9), pp.4815~4822 (2012)
- Wang L, "S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13", Acta Biochim Pol, 59(4), pp.593~598 (2012)
- Gao W, "Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2", Ann Rheum Dis, 72(6), pp.1080~1088 (2013)
- Aricò A, "Matrix metalloproteinases and vascular endothelial growth factor expression in canine leukaemias", Vet J, 196(2), pp.260~262 (2013)
- Yarani R, "In vitro inhibition of angiogenesis by hydroalcoholic extract of oak (Quercus infectoria) acorn shell via suppressing VEGF, MMP-2, and MMP-9 secretion", Pharm Biol, 51(3), pp.361~368 (2013)
- Siejka A, "GHRH antagonist inhibits focal adhesion kinase(FAK)and decreases expression of vascular endothelial growth factor(VEGF) in human lung cancer cells in vitro", Peptides, 37(1), pp.63~68 (2012)
- Li X, "Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and matrix metalloproteinase-2in sacral chordomas", Oncol Lett, 3(6), pp.1268~1274 (2012)
